Uniting the Globe in the Fight Against Gynecologic Cancer
FINAL PROGRAMME
REGIONAL IGCS MEETING 2015SANTIAGO, CHILE MAY 10-12, 2015
TH
International Gynecologic Cancer Society
www.igcsregional.com www.igcs.org
The Chilean Society of Obstetrics and
Gynecology (SOCHOG)
The Chilean Society of Gynecologic Oncology
(SCHIGO)
www.igcs2016.com
16TH BIENNIAL MEETING OF THE
INTERNATIONAL GYNECOLOGIC CANCER
SOCIETYOctober 29 - 31, 2016
Lisbon, Portugal
UNITING THE GLOBE IN THE FIGHT AGAINST GYNECOLOGIC CANCER
Meeting Secretariat:Kenes International7, rue François-Versonnex C.P. 60531211 Geneva 6, SwitzerlandTel: +41 (22) 908-0488, Fax: +41 (22) 906-9140E-mail: [email protected]: www.igcs2016.com
For Membership: International Gynecologic Cancer Society (IGCS), PO Box 6387Louisville, KY 40206, USATel: +1 (502) 891-4575 Fax: +1 (502) 891-4576E-mail: [email protected]: www.igcs.org
SYMPOSIUM ROCHEProgram Symposium
4th Regional IGCS Meeting 2015, SantiagoMay 10, 2015
Hotel Intercontinental
12:30 -12:35 hrs. Welcome Dra. Ximena Ahumada
12:35 -12:50 hrs. Introduction Cervical Cancer in Chile Dr. Nicanor Barrena
12:50 -13:20 hrs. "Update in the management of Dr. Krishnansu S. Tewari advanced cervical cancer, the role of bevacizumab, 13:20 - 13:30 hrs. Discussion
www.igcs2016.com
16TH BIENNIAL MEETING OF THE
INTERNATIONAL GYNECOLOGIC CANCER
SOCIETYOctober 29 - 31, 2016
Lisbon, Portugal
UNITING THE GLOBE IN THE FIGHT AGAINST GYNECOLOGIC CANCER
Meeting Secretariat:Kenes International7, rue François-Versonnex C.P. 60531211 Geneva 6, SwitzerlandTel: +41 (22) 908-0488, Fax: +41 (22) 906-9140E-mail: [email protected]: www.igcs2016.com
For Membership: International Gynecologic Cancer Society (IGCS), PO Box 6387Louisville, KY 40206, USATel: +1 (502) 891-4575 Fax: +1 (502) 891-4576E-mail: [email protected]: www.igcs.org
SYMPOSIUM ROCHEProgram Symposium
4th Regional IGCS Meeting 2015, SantiagoMay 10, 2015
Hotel Intercontinental
12:30 -12:35 hrs. Welcome Dra. Ximena Ahumada
12:35 -12:50 hrs. Introduction Cervical Cancer in Chile Dr. Nicanor Barrena
12:50 -13:20 hrs. "Update in the management of Dr. Krishnansu S. Tewari advanced cervical cancer, the role of bevacizumab, 13:20 - 13:30 hrs. Discussion
4
TABLE OF CONTENTS
MEETING INFORMATION Venue Map 5
Welcome Letter 6
Committees 7
General Information 8
About Santiago 10
Information for Presenters and Chairpersons 11
Poster Session Overview 12
SCIENTIFIC PROGRAMME Sunday, May 10, 2015 13
Monday, May 11, 2015 17
Tuesday, May 12, 2015 20
Poster Session 21
Index of Authors 29
RECOGNITION, ACKNOWLEDGEMENTS AND INDUSTRY SUPPORTAcknowledgements 32
Company Organised Satellite Symposium 32
Exhibitor and Sponsor Profiles 33
IGCS2015
5
VENUE MAP RE
GIST
RAT
ION
HALL B HALL A
REGI
STRA
TIO
N
EXHIBITION AREA HALL A
POSTER AREA
TUESDAY, MAY 12
SUNDAY, MAY 10 AND MONDAY, MAY 11
6
Dear Colleagues,
On behalf of IGCS President Richard Barakat, the Scientific Programme Committee, the Local Organizing Committee, the Chilean Society of Gynecologic Oncology (SCHIGO), the Chilean Society of Obstetrics and Gynecology (SOCHOG) and the Officers and Council of the IGCS, it is our great pleasure to welcome you to the 4th IGCS Regional Meeting on Gynecologic Cancers taking place in Santiago, one of the most attractive and beautiful cities in South America.
Santiago is Chile's capital city. The imposing Andes Mountains rise majestically around it, with their snow-capped summits and hills that slope down to the very heart of the city. Its setting in the center of a fertile valley and its pleasant Mediterranean climate make it a modern and lively city all year round. From a tourist point of view and due to its location, you are able to be on the mountains, watching the ocean or enjoying different landscapes all in less than a ninety-minute drive.
IGCS Regional Meetings offer collaborative state-of-the-art educational sessions on topics, including cancer prevention, surgical techniques, chemotherapy, radiation therapy, and palliative care. Over three full days, attendees will have the opportunity to participate in lectures, tumor boards, debates, and live surgical training.
We look forward to welcoming you to the congress and wish you a pleasant stay.
WELCOME LETTER
Dr. Raimundo Correa Co-Chair, Scientific Programme Committee
Dr. Michael A. Bookman Co-Chair, Scientific Programme Committee
Dr. Richard Barakat President, IGCS
IGCS2015
7
COMMITTEES
INTERNATIONAL GYNECOLOGIC CANCER SOCIETY OFFICERSPresident Richard R. Barakat, USA Past President Lynette A. Denny, South Africa President Elect Michael A.Quinn, AustraliaVice President Allan L. Covens, CanadaSecretary-Treasurer Robert L. Coleman, USA Secretary-Treasurer Elect Walter H. Gotlieb, Canada
INTERNATIONAL GYNECOLOGIC CANCER SOCIETY COUNCIL MEMBERSNadeem R. Abu-Rustum, USARoberto Angioli, ItalyHennie Botha, South AfricaPatricia J. Eifel, USAGini F. Fleming, USAThomas J. Herzog, USAJoo-Hyun Nam, KoreaAikou Okamoto, JapanElvio G. Silva, USA
SCIENTIFIC PROGRAMME COMMITTEE Michael A. Bookman, USA – Co-Chair Raimundo Correa, Chile – Co-ChairHennie Botha, South Africa Allan Covens, CanadaMauricio Cuello, ChileWalter Gotlieb, CanadaDavid Mayerson, Chile Raúl Puente, Chile
LOCAL ORGANIZING COMMITTEERaimundo Correa, Local ChairClemente ArabMauricio Cuello (President, SOCHOG)Jorge Brañes Juan Enrique LeivaDavid Mayerson (Past President, SCHIGO)Raúl Puente (President, SCHIGO)
8
GENERAL INFORMATION
MEETING VENUEThe Intercontinental SantiagoVitacura 2885, Las Condes, Región Metropolitana, ChilePhone:+56 2 2394 2000http://www.intercontinental.com/hotels/gb/en/santiago/sclha/hoteldetail
REGISTRATIONThe Registration Desk will be open at the Intercontinental Santiago Hotel as follows:Saturday, May 9, 2015 16:30-20:00 Sunday, May 10, 2015 08.00 -19:00Monday, May 11, 2015 08:00-17:30Tuesday, May 12, 2015 08:00-14:00
PARTICIPANT BADGESUpon registration, you will receive your name badge. You are kindly requested to wear your badge during all Meeting sessions and events.
WIFIFree WIFI will be available at the Meeting. Please be aware that public WIFI capacityis always limited and thefore activities are limited to email and web browsing.Network Name: Intercontinental | Password: igcsreg15
REFRESHMENTSCoffee and lunch will be served in the Exhibition and Poster area at the times indicated in the Scientific Programme.
EXHIBITION OPENING TIMES Sunday May 10, 2015 09:45-19:00Monday, May 11, 2015 09:45-16:30
MEETING ABSTRACTS AVAILABLE ONLINE All the Meeting abstracts are published as an online supplement to the International Journal of Gynecologic Cancer: Volume 25, Supplement 1.
PHOTOGRAPHY AND RECORDING PRIVILEGESNo photography, video recording or audio recording is permitted in the scientific sessions at this Meeting unless otherwise authorized by the Scientific Committee or the Meeting Chairman.
IGCS2015
9
SAFETY AND SECURITYPlease do not leave any bags or suitcases unattended at any time, whether inside or outside session halls.
SMOKING POLICYParticipants are kindly requested to refrain from smoking in all session rooms, poster areas and exhibition.
GUEST ATTENDANCE POLICYAll event activities (including educational sessions, meal functions, exhibit hall, etc.) are exclusively reserved for registered attendees. Non-registered guests (including children, family members, colleagues, etc.) are not allowed in any of the event areas. Badges provided at registration are required for entrance into all functions. This policy will be strictly enforced.
CARING FOR THE ENVIROMENTThe Meeting and appointed Meeting organiser Kenes International are devoted to considering environmentally friendly practice at this meeting and in all of our operations. Our responsibility to our Meeting participants, staff, environment and society is paramount in all of our decisions, policies and practices. We continue to learn and strive to integrate new practices all the time.
IGCS MEMBERSHIPTo learn more about IGCS or to apply for membership, please visit the IGCS desk. For further information refer to www.igcs.org or contact the IGCS administration office at [email protected]
INTERNATIONAL GYNECOLOGIC CANCER SOCIETY (IGCS)PO Box 6387Louisville, KY 40206, USATel: +1 (502) 891 4575Fax: + 1 (502) 891 4576 E-mail: [email protected] Website: www.igcs.org
MEETING SECRETARIAT
7 rue François-Versonnex, C.P. 60531211 Geneva 6, SwitzerlandTel: +41 22 908 0488Fax:+41 22 906 9140E-mail: [email protected]: www.igcsregional.com
10
ABOUT SANTIAGO
Founded in 1541, Santiago has been the capital city of Chile since colonial times. The city has a downtown core of 19th century neoclassical architecture and winding side-streets, dotted by art deco, neo-gothic, and other styles. Mountains of the Andes chain can be seen from most points in the city. The city outskirts are surrounded by vineyards, and Santiago is within a few hours of both the mountains and the Pacific Ocean.
Santiago's steady economic growth over the past few decades has transformed it into a modern metropolis.
Only a few historical buildings from the Spanish colonial period remain in the city. In the center of Santiago are several buildings built during the Spanish domination and that mostly correspond to, as the Metropolitan Cathedral begun in 1748 and ended in 1800 and the Church of San Francisco (1586). Other buildings of the period are those located on the sides of Plaza de Armas, established as the city square in 1541. These include the former seat of government, the Palacio de la Real Audiencia de Santiago built between 1804 and 1807, and the Casa Colorada (1769).
Most of the museums are located in the historic city center, occupying the old buildings of colonial origin, such as the National History Museum, located in the Palacio de la Real Audiencia. La Casa Colorada houses the Museum of Santiago, while the Colonial Museum is housed in a wing of the Church of San Francisco. The Museum of Fine Arts, though it is located in the city center, was built in the early twentieth century, and the Museum of Contemporary Art established in 1947.
The Quinta Normal Park, was founded in 1841 for greenhouses to cultivate foreign plant species. The park is now 35.5 hectares (88 acres). The park has a new water feature that include paddle boats. There are also several museums, Artequin Museum an interactive and educational art museum, the Museum of Science and Technology and the train museum, Museo Ferroviario.
There is an extensive network of bicycle trails in the city, especially in the Providencia comuna. The longest section is the Americo Vespuccio road, which contains a very wide dirt path with many trees through the center of a street used by motorists on both sides. The next longest path is along the Mapocho River along avenida Andrés Bello.
IGCS2015
11
Please check the PROGRAMME in case of last minute scheduling changes.
ORAL PRESENTATIONS DATA PRESENTATION:If using a PowerPoint (or any other computer) presentation, please note you need to bring it on a CD, a DVD or on a “disk on key” Memory stick (using the USB port in the computer) and load it on one of the Meeting’ computers in the hall you are speaking in, at least 1 hour before the start of the session.
Please note that the Meeting computers in the session halls are being supplied with Office 2010.
Alternatively you may supply your own laptop computer. In such a case please confirm that it has a VGA socket for external signal and come to check it first in the hall you are speaking in as soon as you arrive.
IMPORTANT NOTE FOR MACINTOSH USERSIn order to use MAC presentations on a PC compatible computer please note that you need to prepare it according to the instructions below, before bringing it to the hall:
1. Use a common font, such as Arial, Times New Roman, Verdana etc. (special fonts might be changed to a default font on a PowerPoint based PC).
2. Insert pictures as JPG files (and not TIF, PNG or PICT-these images will not be visible on a PowerPoint based PC ).
3. Use a common movie format, such as AVI and WMV (MOV files from QuickTime will not be visible on a PowerPoint based PC).
Alternatively you may use your own Macintosh laptop computer. In such a case please confirm you provide it with a VGA adaptor for external signal and come to check it first in the hall you are speaking in as soon as you arrive.
Please note that VHS Video projection, 35 mm’ slide projection and Overhead projection (projection of transparencies) will not be available.
INFORMATION FOR PRESENTERS AND CHAIRPERSONS
12
POSTER PRESENTATIONS
Please see the scientific programme for the board number on which you should display your poster. There is one poster session scheduled for Sunday, May 10, 2015 - Monday, May 11, 2015
POSTER MOUNTING AND DISMANTLINGPoster Presentations will be on display for the duration of the Meeting.
Posters may be mounted between 07:00 – 08:00 on Sunday, May 10, 2015 and dismantled at end of day on Monday, May 11, 2015.
Each poster presenter is requested to stand by his/her poster for informal discussion during the morning and afternoon coffee/lunch breaks.
POSTER AREAAll poster boards will be situated in the poster area.
POSTER SESSION OVERVIEW Topic Board Number
Breast Cancer 1-5
Cervical Cancer 6-31
Gestational Trophoblastic Neoplasia 32-33
Imaging / Staging 34-35
Nursing, Symptom Management, Palliation 36-38
Ovarian Cancer 39-52
Uterine Cancer, including Sarcoma 53-58
Vulvar and Vaginal Cancer 59-60
Presentation No.
SCIENTIFIC PROGRAMME
13
SCIENTIFIC PROGRAMMESUNDAY, MAY 10, 2015
8:45 - 10:15 Hall A
INTERNATIONAL OPPORTUNITIESChairs: M. Quinn (Australia) 1 A. Bermudez (Argentina) 2
8:45 Welcome to Santiago and the IGCS Regional Meeting 3R. Correa (Chile)
9:00 PRESIDENTIAL ADDRESS: What Latin American Oncologists Should Expect from IGCS 4R. Barakat (USA)
9:15 How Latin America Could Contribute to Gynecologic Oncology Research 5M. Bookman (USA)
9:30 Current Status of Collaborative Clinical Research in South America 6A. Lopes da Silva Filho (Brazil)
9:45 The Role of Palliative Care / Supportive Oncology Team 7R. Correa (Chile)
10:00 Panel Discussion, Regional Clinical Research 8
10:15 - 10:30
COFFEE BREAK
SUN
DAY, M
AY 10, 2015
Presentation No.
SUNDAY, MAY 10, 2015
14
10:30 - 11:30 Hall A
EMERGING SURGICAL PRACTICEChairs: T. Herzog (USA) 14 D. Mayerson (Chile) 15
10:30 Sentinel Lymph Node Mapping for Endometrial Cancer: A Modern Staging Approach 16N. Abu-Rustum (USA)
10:45 Role of Laparoscopy in Gynecologic Oncology 17A. Covens (Canada)
11:00 Advantages of Robotic Surgery over Laparoscopic Approach in Gynecological Malignancies 18W. Gotlieb (Canada)
11:15 Panel Discussion, Regional Surgical Practices 19
11:30 - 12:30 Hall A
MANAGEMENT OF VULVAR CANCERChairs: M. Plante (Canada) 9 A. Zevallos (Peru) 10
11:30 Surgical Considerations in the Management of Vulvar Cancer 11H. Botha (South Africa)
11:50 Adjuvant Treatment for Vulvar Cancer 12P.J. Eifel (USA)
12:10 Panel Discussion, Vulvar Cancer Management (+/- case presentation) 13
12:30 - 13:30 Exhibition Area
LUNCH BREAK
SUN
DAY
, MAY
10,
201
5
Presentation No.
SCIENTIFIC PROGRAMME
15
12:30 - 13:30 Hall A
SYMPOSIUM SPONSORED BY ROCHE CHILE LTDA: UPDATE IN THE MANAGEMENT OF ADVANCED CERVICAL CANCER, THE ROLE OF BEVACIzUMAB 12:30 Welcome
X. Ahumada (Chile)
12:35 Introducción Cáncer Cérvix en Chile N. Barrena (Chile)
12:50 Update in the management of advanced cervical cancer, the role of Bevacizumab K. S. Tewari (USA)
13:20 Discussion
13:30 - 15:30 Hall A
CERVICAL CANCER IChairs: R. Anorlu (Nigeria) 21 H. Ramirez (Colombia) 22
13:30 Strategies for Cervical Cancer Prevention in Latin America: Past, Present and Future 23S. Tatti (Argentina)
14:00 Panel Discussion: Cervical Cancer Prevention 24A. Velasquez (El Salvador), O. Nazzal (Chile), J. Tisné (Chile)
14:30 Fertility Sparing Options in Cervical Cancer 27M. Plante (Canada)
14:50 Radical Abdominal Trachelectomy with SLN for Stage IB1 Cervical Cancer 28N. Abu-Rustum (USA)
15:10 Panel Discussion, Fertility Sparing Surgery 29
SUN
DAY, M
AY 10, 2015
Presentation No.
SUNDAY, MAY 10, 2015
16
15:30 - 16:00 Exhibition Area
COFFEE BREAK
16:00 - 17:30 Hall A
CERVICAL CANCER IIChairs: G. Fleming (USA) 31 G. Herbert (Mexico) 32
16:00 Is There a Role for Neoadjuvant Chemotherapy of Cervical Cancer? 33A. Soderini (Argentina)
16:20 Optimal Integration of Radiation Therapy in the Management of Locally Advanced Cervical Cancer 34P.J. Eifel (USA)
16:40 Uterine Sarcomas 35T. Herzog (USA)
17:00 - 17:30 Hall A
TUMOR BOARD I17:00 TUMOR BOARD: Cervical Cancer (Regional Cases)
Speakers and Chairs: G. Baiocchi (Brazil) 36 J. Rutgers (USA) 37
K.S. Tewari (USA) 37A
17:45
OPENING CEREMONY
SUN
DAY
, MAY
10,
201
5
Presentation No.
SCIENTIFIC PROGRAMME
17
Presentation No.
SCIENTIFIC PROGRAMMEMONDAY, MAY 11, 2015
8:30 - 10:30 Hall A
ENDOMETRIAL CANCERChairs: A. Okamoto (Japan) 38 R. Puente (Chile) 39
8:30 Current Staging and Pathological Considerations in Endometrial Cancer 40J. Rutgers (USA)
8:50 Clinical Significance of Non-Endometrioid Tumors 41M. Bookman (USA)
9:10 Radiotherapy in Endometrial Cancer 42P.J. Eifel (USA)
9:30 Chemotherapy in Endometrial Cancer 43G. Fleming (USA)
9:50 Panel Discussion, Endometrial Cancer (+/- cases) 44
10:30 - 11:30 Exhibition Area
COFFEE BREAK AND POSTER VIEWING
MO
ND
AY, MAY 11, 2015
Presentation No.
MONDAY, MAY 11, 2015
18
Presentation No.
11:30 - 12:45 Hall A
ABSTRACT PRESENTATIONSChairs: M. Bookman (USA) R. Puente (Chile)
11:30 NEOADJUVANT CHEMOTHERAPY FOLLOWED BY RADICAL SURGERY COMPARED WITH CONCURRENT CHEMOTHERAPY IN STAGE IB2- IIIB CERVICAL CANCER. LONG-TERM RESULTS IN A PROSPECTIVE RANDOMIzED TRIAL 46J. Vidaurreta, E. Castro Nessim, S. Bover, C. Hernandez, N. Vargas, C. Vico (Argentina)
11:40 Discussion 47
11:45 SURVIVAL COMPARISONS BETWEEN PRIMARY DEBULKING SURGERY AND NEO-ADJUVANT CHEMOTHERAPY IN THE MANAGEMENT OF ADVANCED EPITHELIAL OVARIAN CANCER - AN ANALYSIS OF SEER-MEDICARE DATA 48G. Forde, J. Chang, A. ziogas, R. Bristow (USA)
11:55 Discussion 49
12:00 ASSIGNING SITE OF ORIGIN IN HIGH GRADE SEROUS CANCER - BRIDGING THE GAP BETWEEN RESEARCH AND CLINICAL PRACTICE 50S. Lio, J. Arseneau, O. Basso, L. Gilbert (Canada)
12:10 Discussion 51
12:15 ROLE OF VIDEO-ASSISTED THORACOSCOPY IN ADVANCED OVARIAN CANCER 52J. Di Guilmi, G. Salvo, A.M. Nick, A.K. Sood, R.L. Coleman, K.H. Lu, R. Mehran, A. Vaporciyan, P.T. Ramirez (Argentina)
12:25 Discussion 53
12:30 NEOADJUVANT CHEMOTHERAPY IN VULVAR CANCER: A POSSIBLE NEW TREND IN LOCALLY ADVANCED DISEASE 54A. Aragona, A. Soderini, N. Cuneo, C. Reyes, S. Leckmann, A. Greco (Argentina)
12:40 Discussion 55
MO
ND
AY, M
AY 1
1, 2
015
Presentation No.
SCIENTIFIC PROGRAMME
19
Presentation No.
12:45 - 14:00 Exhibition Area
LUNCH BREAK
14:00 - 16:20 Hall A
OVARIAN CANCERChairs: M. Bookman (USA) 57 L.M. Campbell (Brazil) 58
14:00 Pathological Features of Epithelial Ovarian and Associated Cancers 59J. Rutgers (USA)
14:20 Low Malignant Potential Ovarian Tumors 60M. Bookman (USA)
14:40 Is There a Role for Adjuvant Treatment of Early Stage Disease (Serous and Non-serous)? 61M. Quinn (Australia)
15:00 The Role of Neoadjuvant Therapy and Definitions of Residual Disease in 2015 62A. Covens (Canada)
15:20 Optimal Primary Chemotherapy, including Dose-Dense and Intraperitoneal Therapy 63K. Fujiwara (Japan)
15:50 Targeting Recurrent Ovarian Cancer 64J. Ledermann (United Kingdom)
16:20 - 17:30 Hall A
TUMOR BOARD II TUMOR BOARD: Ovarian Cancer (Regional Cases)
Speakers and Chairs: C. Salas (Chile) 65 J. Rutgers (USA) 66 N. Barrena (Chile) 66A
MO
ND
AY, MAY 11, 2015
Presentation No.
TUESDAY, MAY 12, 2015
20
Presentation No.
SCIENTIFIC PROGRAMMETUESDAY, MAY 12, 2015
8:30 - 14:00 Hall A
LIVE SURGICAL SESSIONSChairs: M. Cuello (Chile) 66B J. E. Leiva (Chile) 66C
Surgical Suite Chairs: J. Brañes (Chile) 66D N. Barrena (Chile) 66E
International Surgical Faculty: N. Abu-Rustum (USA) 66F H. Botha (South Africa) 66G
9:00 - 11:00 Hall B
RADIATION ONCOLOGY WORKSHOP: RADIATION ONCOLOGY SYMPOSIUM - CONTOURING AND TARGET VOLUME DEFINITION
Speakers: P.J. Eifel (USA) 66H
A. Cordova (Chile) 66I
14:00 Hall B
FINAL REMARKS AND CLOSE
TUES
DAY
, MAY
12,
201
5
Poster No.
Presentation No.
POSTERS
21
POSTERS
01. Breast Cancer1 NEOADYUVANT HORMONOTHERAPY IN LOCALLY ADVANCED BREAST
CANCER, POSMENOPAUSIC WOMEN WITH HORMONAL RECEPTORS POSITIVE. 75N. Arturo, A. Novoa (Mexico)
2 SERIAL RESECTIONS IN METASTATIC BREAST CANCER 76N. Bacabasa, I. Dinu, A. Martiniuc, L. David (Romania)
3 COSMETIC OUTCOME ASSESSMENT AFTER NEOADJUVANT RADIOCHEMOTHERAPY IN BREAST CANCER PATIENTS 77E. Boelke, W. Budach, V. Speer, S. Wollandt, P.A. Gerber, W. Audretsch, C. Nestle Krämling, C. Matuschek (Germany)
4 MANAGEMENT OF MICROMETASTASIS FOUND ON SENTINEL LYMPH NODE BIOPSY USING OSNA IN PATIENTS DIAGNOSED WITH EARLY BREAST CANCER 78M. Chopra, F. Alam, Y. Mir, S. Mc Pherson, L. Richards, H. Wong (United Kingdom)
5 NEW ASPECTS REGARDING NEOADJUVANT RADIOCHEMOTHERAPY IN LOCALLY ADVANCED NONINFLAMMATORY BREAST CANCER AND PREDICTIVE FACTORS FOR A PATHOLOGIC COMPLETE REMISSION 79C. Matuschek, E. Boelke, W. Budach, V. Speer, H. Bojar, W. Audretsch, K. Nestle (Germany)
02. Cervical Cancer6 ACCURACY OF 18 F-FDG PET/CT FOR THE DETECTION OF PARA-AORTIC
LYMPH NODE METASTASIS IN PATIENTS WITH EARLY BULKY AND LOCALLY ADVANCED UTERINE CERVICAL CARCINOMA.FIRST NATIONAL EXPERIENCE 80D. Acuña Aravena, R. Pruzzo, N. Barrena, H. Amaral, P. Torres, Y. McConell, S. Ramírez (Chile)
7 ATYPICAL HEPATECTOMY FOR LIVER METASTASES FROM CERVICAL CANCER 81N. Bacabasa, I. Balescu, C. Stoica (Romania)
POSTERS
Poster No.
Presentation No.
POSTERS
22
8 CLINICAL ADVANTAGES OF NERVE-SPARING RADICAL HYSTERECTOMY OF CERVICAL CANCER 82S. Parry, H. Riesle, C. Bazan (Chile)
9 CERVICAL CANCER AND PREGNANCY: THREE CASES DURING 2014 IN CARLOS VAN BUREN HOSPITAL, VALPARAISO-CHILE 83H. Riesle, S. Parry, C. Bazan (Chile)
10 AVALIATION OF RESIDUAL DISEASE IN HYSTERECTOMY SPECIMENS AFTER CONIzATION IN WOMEN TREATED FOR SQUAMOUS MICROINVASIVE CARCINOMA OF THE UTERINE CERVIX 84C.A. Hartman, M.S.C. Gurgel, J.C. Teixeira, S.M. Figueiredo, J.Y. Yoneda, O.F. Rangel, J. Braganca Bastos (Brazil)
11 O&G RESIDENTS IN BRAzIL WOULD CONSIDER GYNECOLOGIC ONCOLOGY AS A SUBSPECIALTY IF IT WERE OFFICIALLY RECOGNIzED AND DON'T FEEL READY TO PERFORM RADICAL HYSTERECTOMIES 85L. Campbell, W. Primo, R. Miziara, P. Brito, L. Casulari (Brazil)
12 SURVIVAL OF CERVICAL CANCER TYPE SQUAMOUS AND ADENOCARCINOMA IN PATIENTS FROM THE NATIONAL CANCER INSTITUTE, BETWEEN 2009-2013, CHILE 86P. Gayan, M. Villalobos, C. Wendling, C. Sierra, O. Valencia, M. Carcamo, S. Prado, A. Selman, J. Garrido (Chile)
13 CLINICAL OUTCOMES AND HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WHO HAD UNDERGONE TOTAL LAPAROSCOPIC VERSUS TOTAL ROBOTIC RADICAL HYSTERECTOMY FOR CERVICAL CARCINOMA 87H. Dae Gy, J.Y. Kim, Y.H. Lee, G.O. Chong, Y.S. Lee, Y.L. Cho (Korea)
14 THE VALUE OF CYTOKERATIN 19 AND HUMAN PAPILLOMA VIRUS DNA AS MICROMETASTASIS MARKERS IN CERVICAL CANCER PATIENTS WITH INTERMEDIATE RISK FACTORS 88H. Dae Gy, M.J. Kim, Y.H. Lee, G.O. Chong, Y.S. Lee, Y.L. Cho, J.Y. Park (Korea)
15 LAPAROSCOPIC RADICAL TRACHELECTOMY: TECHNIQUE, FEASIBILITY AND OUTCOMES. EXPERIENCE HOSPITAL ITALIANO BUENOS AIRES, ARGENTINA 89J.M. Saadi, M. Perrotta, M. Giavedoni, G. Salvo, R. Orti (Argentina)
16 APOPTOTIC PATHWAY OF zINC ON CERVICAL CANCER CELL LINE 90S.N. Bae, E.Y. Ki, H.K. Chang, Y.K. Lee, K.H. Lee (Korea)
POST
ERS
Poster No.
Presentation No.
POSTERS
23
17 VAGINAL RADICAL TRACHELECTOMY. A 10 YEARS EXPERIENCE OF 3 CENTERS IN CHILE 91A. Lehuede Massa, N. Saez Orellana, M. Cuello Fredes, K. Garcia Astudillo, D. Majerson Burztyn, C. Paredes Martinez, M. Hinostroza Scheel, D. Young Hwang, J. Brañes Yunusic (Chile)
18 TREATMENT AND OUTCOME OF STAGE I A1 SQUAMOUS CARCINOMA OF THE CERVIX: A CLINICOPATHOLOGIC STUDY OF 346 CASES 92M.R. Liang, S.Y. zeng, W. Jiang, L. Li, M.L. zhong, O.P. Huang (China)
19 LAPAROSCOPIC PARAAORTIC INFRARENAL LYMPHADENECTOMY: ANATOMICAL ANOMALIES FOUND IN OUR SERIES OF CASES AT THE GYNECOLOGIC ONCOLOGY SECTION , DEPARTMENT OF GYNECOLOGY , HOSPITAL ITALIANO DE BUENOS AIRES. 93F. Noll, J. Saadi, D. Odetto, G. Saraniti, M. Perrotta (Argentina)
20 LAPAROSCOPIC POSTERIOR EXENTERATION IN CERVICAL CANCER: INITIAL EXPERIENCE AT HOSPITAL ITALIANO DE BUENOS AIRES 94D. Odetto, J. Saadi, G. Saraniti, F. Noll, G. Salvo, M. Perrotta (Argentina)
21 HYPOXIA AND BIOMARKERS EXPRESSION IN CERVICAL CANCER (CC) AND HIGH GRADE SQUAMOUS INTRAEPITHELIAL LESIONS (HSIL) 95M.A. Ostojich, S. Gianni, L. Marino, E. Lupo, D. De Dios, N. zeff, L. Lay, F. Damiani, A. Sanchez, L. Gimenez, M.A. Jasnis (Argentina)
22 SURVIVAL IN CERVICAL CANCER PATIENTS TREATED BY MINIMALLY INVASIVE SURGERY 96S. Pessini, G.P.G. Silveira, M.P. Salcedo, M.C.B. Anselmi (Brazil)
23 POSITIVE MARGINS IN COLD KNIFE CONE: PREVALENCE AND RESIDUAL LESIONS 97R.V. Almeida, M.P. Salcedo, D. Gottlieb, D.P. Todeschini, S.A. Pessini (Brazil)
24 BIOMARKER ASSESSMENT IN CERVICAL UTERINE CANCER 98R. Medina-Berlanga, S. Blancas, L. Santos (Mexico)
25 TREATMENT OUTCOMES OF PATIENTS WITH EARLY STAGE CERVICAL CANCER TREATED WITH LAPAROTOMY COMPARED TO ROBOTICALLY ASSISTED LAPAROSCOPIC APPROACH 99K. Seader, S. Rao, Y. Hemida, E. Hashemi, M. Pitter, P. Anderson, G. Sommers (USA)
POSTERS
Poster No.
Presentation No.
POSTERS
24
26 DETECTION OF E6-E7 MRNA OF HIGH RISK HUMAN PAPILLOMAVIRUS IN NEGATIVE LYMPH NODES IN PATIENTS WITH CERVICAL CANCER: A POSSIBLE EARLY BIOMARKER OF SUBCLINICAL METASTASIS 100J.A. Basiletti, M.A. Picconi, S. Vornetti, A. Soderini, N. Cúneo, G. Etcheverry, L.V. Alonio (Argentina)
27 THE ABDOMINAL RADICAL TRACHELECTOMY SPARING THE UTERINE ARTERIES ( A.R.T.- S.U.A) & THE PELVIC AUTONOMIC PLEXUS (P.P.A.P.) IN CERVICAL CANCER (CC): ONCOLOGICAL & FERTILITY OUTCOMES OF THIS NOVEL SURGICAL TECHNIQUE 101A. Soderini, A. Aragona, E. Bonavía, P. Mollar Vigh, M.V. Minaudo, E. Petrocino, L. Di Biase, N. Cuneo (Argentina)
28 UTERINE CERVICAL CANCER RECURRENCE PATTERN IN HIGUERAS HOSPITAL,TALCAHUANO - CHILE,BETWEEN 2003 AND 2014. 102A. Vigueras, M. Hinostroza, J. Araneda, A. Moraga (Chile)
29 CYTOHISTOLOGICAL CORRELATION IN CPU HIGUERAS HOSPITAL, TALCAHUANO - CHILE, BETWEEN 2003 AND 2014. 103E. Vivaldi, A. Vigueras, V. Ruf (Chile)
30 DISEASE RECURRENCE AFTER LOOP TREATMENT FOR HIGH GRADE CERVICAL INTRAEPITHELIAL NEOPLASIA 104J.Y. Yoneda, L.C. zeferino, M. Marangoni, M.P. Funari, T. Sapper, C.A. Hartman, O.F. Rangel, J.F. Braganca (Brazil)
31 EVALUATION OF CONE DEPTH TO ACHIEVE NEGATIVE MARGINS AFTER ELECTROSURGICAL TREATMENT FOR HIGH GRADE CERVICAL INTRAEPITHELIAL NEOPLASIA 105J.Y. Yoneda, L.C. zeferino, M.P. Funari, M. Marangoni, T. Sapper, E.C. Candido, J.F. Braganca (Brazil)
03. Gestational Trophoblastic Neoplasia32 GESTATIONAL TROPHOBLASTIC DISEASE: INCREASE OF INCIDENCE IN
CARLOS VAN BUREN HOSPITAL, VALPARAISO - CHILE 106C. Bazan, S. Parry, H. Riesle (Chile)
33 MOLECULAR CHARACTERIzATION OF GESTATIONAL TROPHOBLASTIC DISEASE 107I. Castillo, J. Lopez, J.E. Leiva, C. Paredes, R. Correa (Chile)
POST
ERS
Poster No.
Presentation No.
POSTERS
25
04. Imaging / Staging34 ROLE OF INDOCYANINE GREEN (ICG) IN SENTINEL NODE MAPPING IN
GYNECOLOGIC CANCER: A TIME FOR A NEW STANDARD OF CARE? 108M.C. Darin, N. Rodriguez Gómez-Hidalgo, P. Escobar, M. Frumovitz, P.T. Ramirez (Argentina)
35 LAPAROSCOPIC TREATMENT FOR ISOLATED PARA-AORTIC LYMPH NODE RECURRENCE 109G. Saraniti, M.T. Labanca, J.M. Saadi, R. Orti, M. Perrotta (Argentina)
05. Nursing, Symptom Management, Palliation36 MOST QUALITY OF LIFE QUESTIONNAIRES USED IN PEER-REVIEWED
CERVICAL CANCER SURVIVALS SURVEYS ARE NOT DISEASE-SPECIFIC INSTRUMENTS AND HAVE NOT BEEN PREVIOUSLY VALIDATED 110L.M. Campbell, W.Q. Primo, R.F. Miziara, P.V. Brito, L.A. Casulari (Brazil)
37 ASSESSMENT OF POSTOPERATIVE MORBIDITY RISK AFTER HYSTERECTOMY USING THE SURGICAL APGAR SCORE 111T. Shemshedini, T.S. Pradhan, S. Labrecque, F. Moy, S.S. Tedjarati, T.L. Pua (USA)
38 THE RELATIONSHIP BETWEEN SELF-EFFICACY AND ADHERENCE TO PAP TEST IN A GROUP OF CHILEAN WOMEN 112M.T. Urrutia (Chile)
06. Ovarian Cancer39 BRAIN METASTASES FROM EPITHELIAL OVARIAN CANCER: CLINICO-
PATHOLOGICAL FINDINGS. A RETROSPECTIVE SINGLE INSTITUTION STUDY 113R. Correa, C. Paredes, J.E. Leiva, R. Munoz, G. Avendano, I. Castillo (Chile)
40 LEPTIN PROMOTES A MORE AGGRESIVE BEHAVIOR OF OVARIAN CANCER CELLS: A POTENTIAL EXPLANATION FOR A WORSE PROGNOSIS IN OBESE OVARIAN CANCER PATIENTS 114M. Cuello-Fredes, S. Kato, L. Abarzúa-Catalán, A. Delpiano, C. Trigo, K. García, C. Sanhueza, C. Ibañez, J. Brañes, E. Castellon, G. Owen (Chile)
POSTERS
Poster No.
Presentation No.
POSTERS
26
41 DIFFERENTIALLY EXPRESSED MIRNAS AND THEIR SURVIVAL PREDICTION IN THE HIGH GRADE SEROUS AND CLEAR CELL OVARIAN CARCINOMA 115S. Cui, G. Wang, X. zhang, X. Wu, J. zhao, X. Yu, Y. Ding (China)
42 ADVANCED STAGE OF EPITHELIAL OVARIAN CANCER (II-IV FIGO STAGE). THE ROLE OF LYMPH NODE DISSECTION 116E. Ismail, Y. Kornovski (Bulgaria)
43 SURGICAL STAGING OF OVARIAN CANCER ( I FIGO STAGE) 117E. Ismail, Y. Kornovski (Bulgaria)
44 ADVANCED OVARIAN CANCER: A CHILEAN UNIVERSITY HOPITAL EXPERIENCE. 118J. Brañes Yunusic, K. Garcia Astudillo, M. Cuello Fredes, D. Majerson Burztyn, N. Barrena Medel, D. Young Hwang, A. Lehuede Massa, N. Saez Orellana, M.V. Perez Mendez (Chile)
45 LIFETIME RISK OF OVARIAN CANCER BASED ON ENDOMETRIOSIS AND OTHER RISK FACTORS 119R. Ness, C. Pearce, D. Stram, A. Berchuck, M. Pike, P. Pharoah (USA)
46 DOES TALC EXPOSURE CAUSE OVARIAN CANCER? 120R. Ness (USA)
47 SEROUS PSAMMOCARCINOMA OF THE OVARY AND PERITONEUM: LONG TERM RECURRENCE 121G. Norese, A. Moreira, S. Alessandria, F. Gorosito, M.J. Lange, A. Bermudez (Argentina)
48 IFOSFAMIDUM AS PALLIATIVE TREATMENT FOR ADVANCED OVARIAN CANCER 122S. PLATE, z. zvirbule, S. Kasperova (Latvia)
49 CLINICAL MANAGEMENT OF BORDERLINE OVARIAN TUMORS IN DR SOTERO DEL RIO HOSPITAL 123O. Puga, M.V. Perez, M. Farias, N. Saez, M.I. Barriga, K. Garcia, M. Saavedra, M. Fernandez, T. Rodriguez (Chile)
50 NHE1 PROMOTE CELL PROLIFERATION IN OVARIAN CANCER: A ROLE OF HYPOXIA-INDUCIBLE FACTORS. 124C. Sanhueza, J. Araos, L. Naranjo, T. Sáez, L. Silva, R. Salsoso, F. Pardo, A. Leiva, M.A. Cuello, M. Cornejo, M.A. Ramírez, L. Sobrevia (Chile)
POST
ERS
Poster No.
Presentation No.
POSTERS
27
51 CAN WE IMPROVE DETECTION OF BORDERLINE OVARIAN TUMORS? 125L. Singh, T. Pua, S. Tedjarati, C. Song, L. LeCompte, T. Pradhan (USA)
52 FIBRIN SEALANT HEMOSTATIC PATCH CLINICAL EFFECTIVENESS EVALUATION IN ADVANCED OVARIAN CANCER PATIENTS UNDERWENT PELVIC LYMPHADENECTOMY: INSTITUTIONAL EXPERIENCE 126D.R. Kaidarova, T.A. Yugai, T.T. Sadykova (Kazakhstan)
07. Uterine Cancer, including Sarcoma53 ROBOTIC SURGERY INCREASES PATIENT’S ACCESS TO MINIMALLY
INVASIVE SURGERY FOR HYSTERECTOMIES 127G. Forde, J. Chang, z. A, K. Tewari, R. Bristow (USA)
54 MOLECULAR FINGERPRINTS OF MIXED ENDOMETRIOID AND SEROUS ADENOCARCINOMA OF THE ENDOMETRIUM. 128P. Mhawech-Fauceglia (USA)
55 EARLY STAGE ENDOMETRIAL CANCER: LAPAROSCOPY VS LAPAROTOMY 129S. Alessandria, G. Norese, F. Gorosito, M.J. Lange, M. Nölting, A. Bermudez (Argentina)
56 THE SIGNIFICANCE OF PRE-OPERATIVE ENDOMETRIAL SAMPLING IN GRADE 1, LOW RISK ENDOMETRIAL CANCERS 130L. Singh, T. Pua, P. Khattar, L. Han, S. Tedjarati, T. Pradhan (USA)
57 TWO CASE OF ATYPICAL ENDOMETRIAL HYPERPLASIA ASSOCIATED WITH “BIOIDENTICAL” HORMONE REPLACEMENT THERAPY 131L. Vrabic Dezman, M.z. Gersak, K. Gersak (Slovenia)
58 UNDIFFERENTIATED ENDOMETRIAL CANCER, A DIFFERENT ENTITY WITH AN AGGRESSIVE BEHAVIOR 132W. Jimenez, J. Maxwell, D. Daya, M. Sur, L. Elit, L. Eiriksson, C. Reade, A. Lytwyn (Canada) PO
STERS
Poster No.
Presentation No.
POSTERS
28
08. Vulvar and Vaginal Cancer59 LASER VAPORIzATION IN VULVAR INTRAEPITHELIAL NEOPLASIA (VIN),
VAGINAL INTRAEPITHELIAL NEOPLASIA (VAIN) AND CONDYLOMATA ACUMINATA 133S. Ramirez, N. Barrena, Y. MC Conell, P. Torres, H. Leon, P. Jimenez, D. Acuna, M. Meneses (Chile)
60 PROGNOSTIC SIGNIFICANCE OF TUMOR SIzE IN SQUAMOUS CELL CARCINOMA OF THE VULVA 134A. Soderini (Argentina)
POST
ERS
IGCS2015
29
INDEX OF AUTHORS
A, z. 127
Abarzúa-Catalán, L. 114
Abu Rustum, N. 16, 28, 66F, 71
Acuña Aravena, D. 80
Acuna, D. 133
Alam, F. 78
Alessandria, S. 121, 129
Almeida, R.V. 97
Alonio, L.V. 100
Amaral, H. 80
Anderson, P. 99
Anorlu, R. 21
Anselmi, M.C.B. 96
Aragona, A. 54, 101
Araneda, J. 102
Araos, J. 124
Arseneau, J. 50
Arturo, N. 75
Audretsch, W. 77, 79
Avendano, G. 113
Bacabasa, N. 76, 81
Bae, S.N. 90
Baiocchi, G. 36
Balescu, I. 81
Barakat, R. 4
Barrena Medel, N. 118
Barrena, N. 66A, 66E, 70, 80, 133
Barriga, M.I. 123
Basiletti, J.A. 100
Basso, O. 50
Bazan, C. 82, 83, 106
Berchuck, A. 119
Bermudez, A. 2, 121, 129
Blancas, S. 98
Boelke, E. 77, 79
Bojar, H. 79
Bonavía, E. 101
Bookman, M. 5, 41, 57, 60
Botha, H. 11, 66G, 72
Bover, S. 46
Braganca Bastos, J. 84
Braganca, J.F. 104, 105
Branes , J. 66D, 69
Brañes Yunusic, J. 91, 118
Brañes, J. 114
Bristow, R. 48, 127
Brito, P. 85
Brito, P.V. 110
Budach, W. 77, 79
Campbell, L. 85
Campbell, L.M. 58, 110
Candido, E.C. 105
Carcamo, M. 86
Castellon, E. 114
Castillo, I. 107, 113
Castro Nessim, E. 46
Casulari, L. 85
Casulari, L.A. 110
Chang, H.K. 90
Chang, J. 48, 127
Cho, Y.L. 87, 88
Chong, G.O. 87, 88
Chopra, M. 78
Coleman, R.L. 52
Cordova, A. 66I, 74
Cornejo, M. 124
Correa, R. 3, 7, 107, 113
Covens, A. 17, 62
Cuello Fredes, M. 91, 118
Cuello-Fredes, M. 114
Cuello, M. 66B, 67
Cuello, M.A. 124
Cui, S. 115
Cuneo, N. 54, 101, 100
Dae Gy, H. 87, 88
Damiani, F. 95
Darin, M.C. 108
David, L. 76
Daya, D. 132
De Dios, D. 95
Delpiano, A. 114
Di Biase, L. 101
Di Guilmi, J. 52
Ding, Y. 115
Dinu, I. 76
Eifel, P.J. 12, 34, 42, 66H, 73
Eiriksson, L. 132
Elit, L. 132
Escobar, P. 108
Etcheverry, G. 100
Farias, M. 123
Fernandez, M. 123
Figueiredo, S.M. 84
Fleming, G. 31, 43
Forde, G. 48, 127
Frumovitz, M. 108
Fujiwara, K. 63
Funari, M.P. 104, 105
30
Garcia Astudillo, K. 91, 118
Garcia, K. 123, 114
Garrido, J. 86
Gayan, P. 86
Gerber, P.A. 77
Gersak, K. 131
Gersak, M.z. 131
Gianni, S. 95
Giavedoni, M. 89
Gilbert, L. 50
Gimenez, L. 95
Gorosito, F. 121, 129
Gotlieb, W. 18
Gottlieb, D. 97
Greco, A. 54
Gurgel, M.S.C. 84
Han, L. 130
Hartman, C.A. 84, 104
Hashemi, E. 99
Hemida, Y. 99
Herbert, G. 32
Hernandez, C. 46
Herzog, T. 14, 35
Hinostroza Scheel, M.
91
Hinostroza, M. 102
Huang, O.P. 92
Ibañez, C. 114
Ismail, E. 116, 117
Jasnis, M.A. 95
Jiang, W. 92
Jimenez, P. 133
Jimenez, W. 132
Kaidarova, D.R. 126
Kasperova, S. 122
Kato, S. 114
Khattar, P. 130
Ki, E.Y. 90
Kim, J.Y. 87
Kim, M.J. 88
Kornovski, Y. 116, 117
Labanca, M.T. 109
Labrecque, S. 111
Lange, M.J. 121, 129
Lay, L. 95
Leckmann, S. 54
LeCompte, L. 125
Ledermann, J. 64
Lee, K.H. 90
Lee, Y.H. 87, 88
Lee, Y.K. 90
Lee, Y.S. 87, 88
Lehuede Massa, A. 91, 118
Leiva, A. 124
Leiva, J.E. 66C, 68, 107, 113
Leon, H. 133
Li, L. 92
liang, M.R. 92
Lio, S. 50
Lopes da Silva Filho, A.
6
Lopez, J. 107
Lu, K.H. 52
Lupo, E. 95
Lytwyn, A. 132
Majerson Burztyn, D.
91, 118
Marangoni, M. 104, 105
Marino, L. 95
Martiniuc, A. 76
Matuschek, C. 77, 79
Maxwell, J. 132
Mayerson, D. 15
MC Conell, Y. 133
Mc Pherson, S. 78
McConell, Y. 80
Medina-Berlanga, R.
98
Mehran, R. 52
Meneses, M. 133
Mhawech-Fauceg-lia, P.
128
Minaudo, M.V. 101
Mir, Y. 78
Miziara, R. 85
Miziara, R.F. 110
Mollar Vigh, P. 101
Moraga, A. 102
Moreira, A. 121
Moy, F. 111
Munoz, R. 113
Naranjo, L. 124
Nazzal, O. 25
Ness, R. 119, 120
Nestle Krämling, C. 77
Nestle, K. 79
Nick, A.M. 52
Noll, F. 93, 94
Nölting, M. 129
Norese, G. 121, 129
Novoa, A. 75
Odetto, D. 93, 94
Okamato, A. 38
Orti, R. 89, 109
Ostojich, M.A. 95
Owen, G. 114
Pardo, F. 124
Paredes Martinez, C.
91
Paredes, C. 107, 113
Park, J.Y. 88
Parry, S. 82, 83, 106
Pearce, C. 119
Perez Mendez, M.V.
118
Perez, M.V. 123
IGCS2015
31
Perrotta, M. 89, 93, 94, 109
Pessini, S. 96
Pessini, S.A. 97
Petrocino, E. 101
Pharoah, P. 119
Picconi, M.A. 100
Pike, M. 119
Pitter, M. 99
Plante, M. 9, 27
PLATE, S. 122
Pradhan, T. 125, 130
Pradhan, T.S. 111
Prado, S. 86
Primo, W. 85
Primo, W.Q. 110
Pruzzo, R. 80
Pua, T. 125, 130
Pua, T.L. 111
Puente, R. 39
Puga, O. 123
Quinn, M. 1, 61
Ramirez, H. 22
Ramírez, M.A. 124
Ramirez, P.T. 52, 108
Ramirez, S. 133, 80
Rangel, O.F. 84, 104
Rao, S. 99
Reade, C. 132
Reyes, C. 54
Richards, L. 78
Riesle, H. 82, 83, 106
Rodriguez Gómez-Hidalgo, N.
108
Rodriguez, T. 123
Ruf, V. 103
Rutgers, J. 37, 40, 59, 66
Saadi, J. 93, 94
Saadi, J.M. 89, 109
Saavedra, M. 123
Sadykova, T.T. 126
Saez Orellana, N. 91, 118
Saez, N. 123
Sáez, T. 124
Salas, C. 65
Salcedo, M.P. 96, 97
Salsoso, R. 124
salvo, G. 94, 52, 89
Sanchez, A. 95
Sanhueza, C. 114, 124
Santos, L. 98
Sapper, T. 104, 105
Saraniti, G. 93, 94, 109
seader, K. 99
Selman, A. 86
Shemshedini, T. 111
Sierra, C. 86
Silva, L. 124
Silveira, G.P.G. 96
Singh, L. 125, 130
Sobrevia, L. 124
Soderini, A. 100, 134, 33, 54, 101
Sommers, G. 99
Song, C. 125
Sood, A.K. 52
Speer, V. 77, 79
Stoica, C. 81
Stram, D. 119
Sur, M. 132
Tatti, S. 23
Tedjarati, S. 125, 130
Tedjarati, S.S. 111
Teixeira, J.C. 84
Tewari, K. 20, 37A, 127
Tisné, J. 26
Todeschini, D.P. 97
Torres, P. 80, 133
Trigo, C. 114
Urrutia, M.T. 112
Valencia, O. 86
Vaporciyan, A. 52
Vargas, N. 46
Velasquez, A. 24
Vico, C. 46
Vidaurreta, J. 46
Vigueras, A. 102, 103
Villalobos, M. 86
Vivaldi, E. 103
Vornetti, S. 100
Vrabic Dezman, L. 131
Wang, G. 115
Wendling, C. 86
Wollandt, S. 77
Wong, H. 78
Wu, X. 115
Yoneda, J.Y. 84, 104, 105
Young Hwang, D. 91, 118
Yu, X. 115
Yugai, T.A. 126
zeferino, L.C. 104, 105
zeff, N. 95
zeng, S.Y. 92
zevallos, A. 10
zhang, X. 115
zhao, J. 115
zhong, M.L. 92
ziogas, A. 48
zvirbule, z. 122
32
RECOGNITION, ACKNOWLEDGEMENTS AND INDUSTRY SUPPORTACKNOWLEDGEMENTSThe Organizing Committee of the 4th Regional IGCS Meeting, 2015 would like to express its gratitude and acknowledge the following for their generous support of the Meeting:
SILVER SPONSOR
EXHIBITORS
COMPANY ORGANIZED SYMPOSIUM Roche Chile LTDA
Friday May 10, 2015 from 12:30 till 13:30
UPDATE IN THE MANAGEMENT OF ADVANCED CERVICAL CANCER, THE ROLE OF BEVACIZUMAB
12:30 -12:35 Welcome - Ximena Ahumada, Chile
12:35 -12:50 Introducción: Cáncer Cérvix en Chile - Nicanor Barrena, Chile
12:50 -13:20 Update in the management of advanced cervical cancer, the role of Bevacizumab - Krishnansu S. Tewari, USA
13:20-13:30 Discussion
IGCS2015
33
SPONSOR AND EXHIBITOR PROFILES
BIOSONDA S.A.Alcalde Eduardo Castillo Velasco 2902 775 0269SantiagoChile www.biosonda.clThe HC2 HPV DNA Test –the gold standard for HPV detection- certified by FDA and CE is produced by digene for Qiagen. It uses a RNA probe cocktail that detects 13 high-risk HPV and 5 low-risk types. To prevent false negatives caused by gene deletions uses a full genome RNA probes complementary to HPV DNA, specific antibodies, signal amplification, and chemiluminescent detection. The HC2 Test can be used with the digene HC2 DNA Collection Device and ThinPrep Pap Test PreservCyt solution to complement PAP. It is currently used for screening of HPV in: Argentina, Mexico, Turkey, Italy and USA among others. HC2 is distributed in Chile by Biosonda S.A.
ECHODATA MEDICAL SYSTEMS CHILE SPAHernando de Aguirre 128, Office 505. ProvidenciaSantiago 7500000Chilewww.echodatallc.comEchodata Medical Systems ha permanecido en crecimiento constante; posicionándose como uno de los proveedores más importantes de Equipos Médicos para Latinoamérica establecidos en la ciudad de Miami y ahora en Chile. Hemos incursionado en el Mercado Chileno a traves de ECHODATA CHILE SpA en la venta y distribución Exclusiva de los Sistemas AMEU (Aspiracion Manual Endo Uterina) destinados al area Gynecologica y de algunos Sistemas dirigidos al tratamiento de lesiones Pre Cancerosas de Cuello Uterino y Cancer Cervical. Nuestra posición como Dealer en los Sistemas AMEU (Aspiracion Manual Endo Uterina), nos ha permitido tener contacto con clientes en toda la región, y nos ha dado el impulso para desarrollar nuevas ideas y conceptos propios, atendiendo y sobrepasando las necesidades de los exigentes mercados. Nuestro objetivo es seguir consolidando estas áreas y continuar innovando, atendiendo los requerimientos del pujante mercado de la salud de Latinoamérica, en especial el mercado Chileno.
F. HOFFMANN-LA ROCHE AG Avenida Cerro el Plomo 5630, P 12, Las CondesRegión MetropolitanaChilewww.roche.cl F. Hoffmann-La Roche AG is a Swiss global health-care company that operates worldwide under two divisions: Pharmaceuticalsand Diagnostics. Its holding company, Roche Holding AGThe company headquarters are located in Basel and the company has many pharmaceutical and diagnostic sites around the world . There are 26 manufacturing sites worldwide.The company owns the American biotechnology company Genentech, which is a wholly owned affiliate, and the Japanese biotechnology company Chugai Pharmaceuticals as well as the Tucson, Arizona based Ventana}In Roche Farma our business focuses on the therapeutic areas of oncology-hematology, rheumatology, transplantation, anemia, hepatitis and Central Nervous System
34
THE CHILEAN SOCIETY OF GYNECOLOGIC ONCOLOGY (SCHIGO)The Chilean Society of Gynecologic Oncology was founded on October 31th, 2001 in Santiago of Chile, with 42 selected founding members. All of them were convened - considering their acknowledged trajectory in the field of gynecologic cancer - by 3 Chairman of Obstetrics and Gynecology Departments of prestigious Chilean universities (Austral University, Catholic University and University of Chile). The first and founder President was Raul Puente MD from Austral University. The aim of the Society was the study of gynecologic cancer as much in prevention as in pathological aspects, but in special in the field of gynecologic oncology surgery. On October 7th, 2004, the Society got its legal status. During 2005, the Society obtained the recognition of Gynecologic Oncology as subspeciality in Chile by CONACEM, an indepent Agency of Certification. Since then, there are numerous gynecologic oncologist board-certified in the country. Since 2004, the Chilean Society of Gynecologic Oncology has organized succesfully 3 National Congress and 2 National Meetings of Gynecologic Oncology with outstanding invited international lecturers, and some of its members have been invited to present in IGCS Meetings.Prof. Raul Puente MD President SCHIGO
THE CHILEAN SOCIETY OF OBSTETRICS AND GYNECOLOGY (SOCHOG)The Chilean Society of Obstetrics and Gynecology was founded on October 15, 1935, in a meeting attended by 19 participants, giving birth to the third of the oldest national scientific associations and the longest fourth of its kind in Latin America .The Society was created with the aim of combining the criteria of the different departments of the specialty and mainstream doctors who excelled in their development, in order to spread the level of the medical establishment and to provide information to the public to improve the quality of care for women. With 80 years of history there are many milestones that have marked the path of SOCHOG, including the creation of the “Chilean Bulletin of Obstetrics and Gynecology” and in the 60s the “Chilean Journal of Obstetrics and Gynecology”, with better design more numbers of pages and bimonthly.In 2007, the Sochog helped the creation of the Chilean Chapter of the American College of Obstetrician and Gynecologists (ACOG), created in 1951.With the Chilean female population going above the 8 million mark, who are averaging the age of 82 years, the objective of the Sochog has been changing and growing. It is from here that the current president, the Doctor Mauricio Cuello Fredes, has found the problem that the SOCHOG has to encounter in its eighth decade. “We want the Gynecologist Obstetrician to go further that a doctor who only worries about the pregnancy, delivery and the puerperal or just the problems associated with gynecology and reproduction. The idea is for them to become a lifelong doctor, a confidant for the woman through her life.
IGCS • PO Box 6387, Louisville • KY 40206, USA • Voice: 1-(502)-891-4575 • FAX: 1-(502)[email protected] • www.igcs.org
Join...The International Communityof Gynecologic Cancer ProfessionalsMember Benefits Include:
Subscription to the peer-reviewed International Journal of Gynecological Cancer, published nine times a yearIGCS Newsletter, published twice a yearIGCS Membership Directory and Speaker’s BureauTravel Scholarships and GrantsVirtual Tumor Board, Journal Club, Lecture Slides, Webcasts, Guidelines, and other educational resourcesReciprocal relationship with other societies
IGCS • PO Box 6387, Louisville • KY 40206, USA • Voice: 1-(502)-891-4575 • FAX: 1-(502)[email protected] • www.igcs.org
Join...The International Communityof Gynecologic Cancer ProfessionalsMember Benefits Include:
Subscription to the peer-reviewed International Journal of Gynecological Cancer, published nine times a yearIGCS Newsletter, published twice a yearIGCS Membership Directory and Speaker’s BureauTravel Scholarships and GrantsVirtual Tumor Board, Journal Club, Lecture Slides, Webcasts, Guidelines, and other educational resourcesReciprocal relationship with other societies
SUNDAY, MAY 10, 2015Time Session
08:45-09:00 Welcome to Santiago and the IGCS Regional Meeting
09:00-09:15 PRESIDENTIAL ADDRESS: What Latin American Oncologists Should Expect from IGCS?
09:15-09:30 How Latin America Could Contribute to Gynecologic Oncology Research
09:30-09:45 Current Status of Collaborative Clinical Research in South America
09:45-10:00 The Role of Palliative Care / Supportive Oncology Team
10:00-10:15 Panel Discussion, Regional Clinical Research
10:15-10:30 Coffee Break, Poster Viewing & Visit the Exhibition
10:30-10:45 Sentinel Lymph Node Mapping for Endometrial Cancer: A Modern Staging Approach
10:45-11:00 Role of Laparoscopy in Gynecologic Oncology
11:00-11:15 Advantages of Robotic Surgery over Laparoscopic Approach in Gynecological Malignancies
11:15-11:30 Panel Discussion, Regional Surgical Practices
11:30-11:50 Surgical Considerations in the Management of Vulvar Cancer
11:50-12:10 Adjuvant Treatment for Vulvar Cancer
12:10-12:30 Panel Discussion, Vulvar Cancer Management (+/- case presentation)
12:30-13:30 Lunch Break, Poster Viewing & Visit the Exhibition
12:30-13:30Update in the Management of Advanced Cervical Cancer. The Role of Bevacizumab - Symposium Sponsored by Roche Chile LTDA
13:30-14:00 Strategies for Cervical Cancer Prevention in Latin America: Past, Present and Future
14:00-14:30 Panel Discussion: Cervical Cancer Prevention
14:30-14:50 Fertility Sparing Options in Cervical Cancer
14:50-15:10 Radical Abdominal Trachelectomy with SLN for Stage IB1 Cervical Cancer
15:10-15:30 Panel Discussion, Fertility Sparing Surgery
15:30-16:00 Coffee Break, Poster Viewing & Visit the Exhibition
16:00-16:20 Is there a Role for Neoadjuvant Chemotherapy of Cervical Cancer?
16:20-16:40Optimal Integration of Radiation Therapy in the Management of Locally Advanced Cervical Cancer
16:40-17:00 Uterine Sarcomas
17:00-17:30 Tumor Board: Cervical Cancer
17:45 Opening Ceremony
MONDAY, MAY 11, 2015 Time Session
08:30-08:50 Current Staging and Pathological Considerations in Endometrial Cancer
08:50-09:10 Clinical Significance of Non-Endometrioid Tumors
09:10-09:30 Radiotherapy in Endometrial Cancer
09:30-09:50 Chemotherapy in Endometrial Cancer
09:50-10:30 Panel Discussion, Endometrial Cancer (+/- cases)
10:30-11:30 Coffee Break, Poster Viewing & Visit the Exhibition
11:30-12:45 Oral Abstracts
12:45-14:00 Lunch Break, Poster Viewing & Visit the Exhibition
14:00-14:20 Pathological Features of Epithelial Ovarian and Associated Cancers
14:20-14:40 Low Malignant Potential Ovarian Tumors
14:40-15:00 Is There a Role for Adjuvant Treatment of Early Stage Disease (Serous and Non-serous)?
15:00-15:20 The Role of Neoadjuvant Therapy and Definitions of Residual Disease in 2015
15:20-15:50 Optimal Primary Chemotherapy, including Dose-Dense and Intraperitoneal Therapy
15:50-16:20 Targeting Recurrent Ovarian Cancer
16:20-17:30 Tumor Board: Ovarian Cancer
TUESDAY, MAY 12, 2015 Time Session08:30-14:00 Surgical Day
09:00-11:00 Radiation Oncology Symposium, Contouring and Target Volume Definition
14:00-14:30 Final Remarks and Close
TIMETABLE
REGIONAL IGCS MEETING 2015SANTIAGO, CHILE MAY 10-12, 2015
TH